Additionally, some drug types (angiotensin II receptor blockers [ARB], angiotensin converting enzyme inhibitors [ACE-I], and calcium-channel blockers [CCB]) and combination therapies appear more effective in combating cognitive decline in HTN than other monotherapy drugs (Kherada et al., 2015). The gene discussed is ACE; the disease is hypertensive disorder.